vs

Side-by-side financial comparison of AETHLON MEDICAL INC (AEMD) and 3M (MMM). Click either name above to swap in a different company.

3M is the larger business by last-quarter revenue ($6.0B vs $60.0K, roughly 100560.3× AETHLON MEDICAL INC). 3M runs the higher net margin — 10.8% vs -2926.4%, a 2937.2% gap on every dollar of revenue. 3M produced more free cash flow last quarter ($2.0B vs $-2.0M).

Aethlon Medical Inc. is a clinical-stage medical technology firm that develops targeted therapeutic devices to address life-threatening health conditions. Its lead product, the Hemopurifier, is designed to remove harmful viruses, cancer-derived exosomes, and other pathogens from the bloodstream. The company primarily operates in the infectious disease and oncology healthcare segments, with main market presence in North America.

The 3M Company is an American multinational conglomerate operating in the fields of industry, worker safety, and consumer goods. Based in the Saint Paul suburb of Maplewood, the company produces over 60,000 products, including adhesives, abrasives, laminates, passive fire protection, personal protective equipment, window films, paint protection film, electrical, electronic connecting, insulating materials, car-care products, electronic circuits, and optical films. Among its best-known consume...

AEMD vs MMM — Head-to-Head

Bigger by revenue
MMM
MMM
100560.3× larger
MMM
$6.0B
$60.0K
AEMD
Higher net margin
MMM
MMM
2937.2% more per $
MMM
10.8%
-2926.4%
AEMD
More free cash flow
MMM
MMM
$2.0B more FCF
MMM
$2.0B
$-2.0M
AEMD

Income Statement — Q3 2025 vs Q1 2026

Metric
AEMD
AEMD
MMM
MMM
Revenue
$60.0K
$6.0B
Net Profit
$-1.8M
$653.0M
Gross Margin
40.7%
Operating Margin
-3026.4%
23.2%
Net Margin
-2926.4%
10.8%
Revenue YoY
1.3%
Net Profit YoY
49.4%
-41.5%
EPS (diluted)
$-10.05
$1.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AEMD
AEMD
MMM
MMM
Q1 26
$6.0B
Q4 25
$6.1B
Q3 25
$6.5B
Q2 25
$6.3B
Q1 25
$6.0B
Q4 24
$60.0K
$6.0B
Q3 24
$95.1K
$6.3B
Q2 24
$6.3B
Net Profit
AEMD
AEMD
MMM
MMM
Q1 26
$653.0M
Q4 25
$577.0M
Q3 25
$834.0M
Q2 25
$723.0M
Q1 25
$1.1B
Q4 24
$-1.8M
$728.0M
Q3 24
$-2.8M
$1.4B
Q2 24
$1.1B
Gross Margin
AEMD
AEMD
MMM
MMM
Q1 26
40.7%
Q4 25
33.6%
Q3 25
41.8%
Q2 25
42.5%
Q1 25
41.6%
Q4 24
51.7%
Q3 24
42.1%
Q2 24
42.9%
Operating Margin
AEMD
AEMD
MMM
MMM
Q1 26
23.2%
Q4 25
13.0%
Q3 25
22.2%
Q2 25
18.0%
Q1 25
20.9%
Q4 24
-3026.4%
12.2%
Q3 24
-3050.2%
20.9%
Q2 24
20.3%
Net Margin
AEMD
AEMD
MMM
MMM
Q1 26
10.8%
Q4 25
9.4%
Q3 25
12.8%
Q2 25
11.4%
Q1 25
18.7%
Q4 24
-2926.4%
12.1%
Q3 24
-2950.2%
21.8%
Q2 24
18.3%
EPS (diluted)
AEMD
AEMD
MMM
MMM
Q1 26
$1.23
Q4 25
$1.07
Q3 25
$1.55
Q2 25
$1.34
Q1 25
$2.04
Q4 24
$-10.05
$1.33
Q3 24
$-16.11
$2.48
Q2 24
$2.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AEMD
AEMD
MMM
MMM
Cash + ST InvestmentsLiquidity on hand
$4.8M
$3.7B
Total DebtLower is stronger
$10.9B
Stockholders' EquityBook value
$4.3M
$3.3B
Total Assets
$6.5M
$35.4B
Debt / EquityLower = less leverage
3.29×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AEMD
AEMD
MMM
MMM
Q1 26
$3.7B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$4.8M
Q3 24
$6.9M
Q2 24
Total Debt
AEMD
AEMD
MMM
MMM
Q1 26
$10.9B
Q4 25
$12.6B
Q3 25
$12.6B
Q2 25
$13.1B
Q1 25
$13.5B
Q4 24
$13.0B
Q3 24
$13.2B
Q2 24
$13.1B
Stockholders' Equity
AEMD
AEMD
MMM
MMM
Q1 26
$3.3B
Q4 25
$4.7B
Q3 25
$4.6B
Q2 25
$4.3B
Q1 25
$4.5B
Q4 24
$4.3M
$3.8B
Q3 24
$6.0M
$4.6B
Q2 24
$3.9B
Total Assets
AEMD
AEMD
MMM
MMM
Q1 26
$35.4B
Q4 25
$37.7B
Q3 25
$37.6B
Q2 25
$38.0B
Q1 25
$40.0B
Q4 24
$6.5M
$39.9B
Q3 24
$8.8M
$40.9B
Q2 24
$43.4B
Debt / Equity
AEMD
AEMD
MMM
MMM
Q1 26
3.29×
Q4 25
2.68×
Q3 25
2.72×
Q2 25
3.06×
Q1 25
3.02×
Q4 24
3.40×
Q3 24
2.84×
Q2 24
3.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AEMD
AEMD
MMM
MMM
Operating Cash FlowLast quarter
$-2.0M
Free Cash FlowOCF − Capex
$-2.0M
$2.0B
FCF MarginFCF / Revenue
-3357.0%
33.6%
Capex IntensityCapex / Revenue
3.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$3.7B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AEMD
AEMD
MMM
MMM
Q1 26
Q4 25
$1.6B
Q3 25
$1.8B
Q2 25
$-954.0M
Q1 25
$-79.0M
Q4 24
$-2.0M
$1.8B
Q3 24
$-2.2M
$-1.8B
Q2 24
$1.0B
Free Cash Flow
AEMD
AEMD
MMM
MMM
Q1 26
$2.0B
Q4 25
$1.3B
Q3 25
$1.5B
Q2 25
$-1.2B
Q1 25
$-315.0M
Q4 24
$-2.0M
$1.5B
Q3 24
$-2.0B
Q2 24
$752.0M
FCF Margin
AEMD
AEMD
MMM
MMM
Q1 26
33.6%
Q4 25
21.8%
Q3 25
23.6%
Q2 25
-18.3%
Q1 25
-5.3%
Q4 24
-3357.0%
25.4%
Q3 24
-32.3%
Q2 24
12.0%
Capex Intensity
AEMD
AEMD
MMM
MMM
Q1 26
Q4 25
4.0%
Q3 25
3.3%
Q2 25
3.3%
Q1 25
4.0%
Q4 24
3.7%
4.8%
Q3 24
0.0%
3.9%
Q2 24
4.3%
Cash Conversion
AEMD
AEMD
MMM
MMM
Q1 26
Q4 25
2.74×
Q3 25
2.11×
Q2 25
-1.32×
Q1 25
-0.07×
Q4 24
2.50×
Q3 24
-1.30×
Q2 24
0.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AEMD
AEMD

Segment breakdown not available.

MMM
MMM

Safety and Industrial business segment$2.9B49%
Transportation and Electronics business segment$1.8B31%
Consumer business segment$1.1B19%
Corporate$121.0M2%

Related Comparisons